PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 68 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

30 August 2024

  1. (diff | hist) 04:33 Timeline of incretin therapeutics 2,186 +341 Chromatokid (talk | contribs) correct the dose ladder — the maintenance dose is not the maximum dose [rollback]
  2. (diff | hist) 03:14 Reference standard 2,872 +411 DrTitration (talk | contribs) expand §Absence of standards in research supply [rollback]

29 August 2024

  1. (diff | hist) m 22:33 Semaglutide 4,857 +54 Chromatokid (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  2. (diff | hist) 19:23 Janoshik Analytical 2,844 +317 EndpointEnid (talk | contribs) add category for certificates of analysis [rollback]
  3. (diff | hist) 09:09 STEP trial programme 3,212 ±0 DataTableDunja (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  4. (diff | hist) m 05:10 Area percent purity 1,808 +487 KarlFischerKit (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  5. (diff | hist) 00:41 SURPASS trial programme 1,993 ±0 EndpointEnid (talk | contribs) label the extension study as an extension study in the table [rollback]
  6. (diff | hist) 00:20 Karl Fischer titration 4,136 +1,323 NewLabNell (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  7. (diff | hist) 00:18 Retatrutide 3,312 +106 IncretinIvo (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  8. (diff | hist) m 00:03 Insulin secretion 2,360 ±0 SatietySunniva (talk | contribs) move the trial material out of §Physiology into the compound articles [rollback]

28 August 2024

  1. (diff | hist) m 23:58 Analytical method validation 2,439 ±0 AnalyticalAnnie (talk | contribs) add the counterion determination method by name [rollback]
  2. (diff | hist) m 19:17 Enteroendocrine L cell 2,621 ±0 AmylinAmos (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  3. (diff | hist) 17:17 Lot traceability 2,176 +172 PanelPlannerPam (talk | contribs) add short description [rollback]
  4. (diff | hist) m 16:54 SURMOUNT trial programme 2,057 ±0 SurmountSurma (talk | contribs) serial comma per PP:MOS [rollback]
  5. (diff | hist) N 15:42 Area percent purity 1,321 +1,321 GlossaryGleb (talk | contribs) create article — method stub
  6. (diff | hist) 13:32 Glucose-dependent insulinotropic polypeptide 4,346 +829 ReceptorRhoda (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]
  7. (diff | hist) 09:52 Talk:Guangzhou JEEP Biotechnology 822 +234 NPOV_Nadia (talk | contribs) /* Concentrated catalogue makes the report set more interpretable */ reply
  8. (diff | hist) m 09:39 Preparative HPLC purification 1,990 +624 MelanocortinMil (talk | contribs) space between number and unit per PP:MOS [rollback]
  9. (diff | hist) m 05:22 Reconstitution of lyophilised peptides 2,854 ±0 BalanceBirdie (talk | contribs) rm the brand-specific instruction; it is not general [rollback]

27 August 2024

  1. (diff | hist) N 22:34 Bacterial endotoxin test 1,436 +1,436 SarcopeniaSefa (talk | contribs) create article — method stub
  2. (diff | hist) 21:31 Limit of detection 1,742 ±0 NewLabNell (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  3. (diff | hist) 15:16 Adverse effects of GLP-1 receptor agonists 2,614 +31 LeanMassLars (talk | contribs) rm the reassurance sentence; the article should report, not reassure [rollback]
  4. (diff | hist) 14:38 Talk:Guangzhou JEEP Biotechnology 611 +240 AnalyticalAnnie (talk | contribs) /* Concentrated catalogue makes the report set more interpretable */ reply
  5. (diff | hist) 11:14 Talk:Guangzhou JEEP Biotechnology 400 +463 TallySheetTad (talk | contribs) /* Concentrated catalogue makes the report set more interpretable */ new section
  6. (diff | hist) 11:03 Vial 6,759 +618 CrudePeptidePearl (talk | contribs) convert the storage conditions to a table [rollback]
  7. (diff | hist) N 09:00 Good manufacturing practice 1,153 +1,153 CarryOverCai (talk | contribs) start article on the regulatory position
  8. (diff | hist) 07:41 Liraglutide 2,493 ±0 IcodecIndra (talk | contribs) add the year of first marketing authorisation, with the regulator named [rollback]
  9. (diff | hist) 05:11 Cagrilintide 1,887 +594 GradientGus (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]

26 August 2024

  1. (diff | hist) 21:41 Intention-to-treat analysis 1,967 ±0 FootnoteFyfe (talk | contribs) consistent en dashes in ranges [rollback]
  2. (diff | hist) 17:37 Mass spectrometry 2,880 ±0 Chromatokid (talk | contribs) expand §What a mass confirms [rollback]
  3. (diff | hist) 14:27 Sterile water for injection 1,810 +585 CDMO_Caradoc (talk | contribs) clarify which volume the graduation marks measure [rollback]
  4. (diff | hist) N 09:00 ISO 9001 1,587 +1,587 TitrationTheo (talk | contribs) start article on the regulatory position
  5. (diff | hist) 08:45 Cold chain 8,537 +927 CDMO_Caradoc (talk | contribs) add the data-logger point: an unlogged shipment has no excursion record [rollback]
  6. (diff | hist) m 06:13 Bacteriostatic water 2,807 +32 ClinicCorrespondent (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  7. (diff | hist) 02:08 Certificate of analysis 1,858 ±0 ChainCustodyChad (talk | contribs) split §What a report shows from §What it does not [rollback]

25 August 2024

  1. (diff | hist) 21:17 Retention time 986 ±0 PeakShapePol (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  2. (diff | hist) m b 11:14 Chinese Peptide Company 2,675 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) 09:54 Insulin syringe 2,340 +257 MoveRequestMio (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]

23 August 2024

  1. (diff | hist) N 09:00 C-peptide 1,892 +1,892 NavboxNiko (talk | contribs) new article: laboratory medicine, expansion welcome
  2. (diff | hist) 07:42 GLP-1 receptor agonist 5,413 +492 CagriCass (talk | contribs) alphabetise the see-also list [rollback]
  3. (diff | hist) 02:34 Resin cleavage 1,678 ±0 FreightFenna (talk | contribs) expand §Isolation [rollback]

22 August 2024

  1. (diff | hist) 23:34 Glossary of peptide terminology 2,271 +238 SerialCommaSeb (talk | contribs) add the missing entry to the list [rollback]
  2. (diff | hist) 23:13 Wuhan Wansheng Biotechnology 4,317 ±0 BetaCellBoyd (talk | contribs) state the city and province of the registered address [rollback]
  3. (diff | hist) 19:58 Tirzepatide 3,725 +54 Chromatokid (talk | contribs) add see also to the amylin analogue [rollback]
  4. (diff | hist) N 15:49 Intention-to-treat analysis 1,967 +1,967 TitrationTheo (talk | contribs) create article — trial programme stub
  5. (diff | hist) m 00:47 WuXi TIDES 3,046 ±0 Retention_Time_Rae (talk | contribs) expand §Notability and coverage [rollback]
  6. (diff | hist) 00:44 Medutest 2,537 +446 Chromatokid (talk | contribs) add the point that reports reaching this wiki are not a sample of anything [rollback]
  7. (diff | hist) 00:37 Janoshik Analytical 2,527 +473 BlindSampleBrid (talk | contribs) split §What a report shows from §What it does not [rollback]

21 August 2024

  1. (diff | hist) m 20:25 Certificate of analysis 1,858 ±0 PrimarySrcPatia (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  2. (diff | hist) 20:07 Research use only 2,879 ±0 ExenatideEzra (talk | contribs) name the regulator rather than writing "the authorities" [rollback]
  3. (diff | hist) 18:25 Insulin secretion 2,360 +814 GsCouplingGil (talk | contribs) clarify that concentrations differ substantially between assay platforms [rollback]
  4. (diff | hist) 17:17 Solid-phase peptide synthesis 2,610 +32 MarginNoteMars (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  5. (diff | hist) 16:09 Peptide synthesis 2,798 +40 TirzTaxonomist (talk | contribs) give the closure integrity test by name [rollback]
  6. (diff | hist) 14:50 Loss on drying 1,231 ±0 ConsensusConal (talk | contribs) add category for method validation [rollback]
  7. (diff | hist) m 14:38 Timeline of incretin therapeutics 1,845 ±0 ExenatideEzra (talk | contribs) sentence case in headings per PP:MOS [rollback]
  8. (diff | hist) N 09:00 Beta cell function 1,687 +1,687 SatietySunniva (talk | contribs) start article on the hormone
  9. (diff | hist) N 09:00 Qingdao Sigma Chemical 1,747 +1,747 BlindSampleBrid (talk | contribs) create organisation article per PP:VN
  10. (diff | hist) m b 08:44 Guangzhou JEEP Biotechnology 4,408 +1,443 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  11. (diff | hist) m 05:38 Fmoc chemistry 2,620 +670 ShortageShona (talk | contribs) expand §The cycle [rollback]
  12. (diff | hist) 05:18 Dual incretin agonist 2,556 ±0 MolarMassMaeve (talk | contribs) expand §Beyond GIP and GLP-1 [rollback]
  13. (diff | hist) 04:48 PeptideMeter 2,054 +878 BatchNumberBede (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]
  14. (diff | hist) 00:01 Subcutaneous injection 2,092 ±0 RetatrutideRuben (talk | contribs) add the cross-link to the calculator page [rollback]

20 August 2024

  1. (diff | hist) m b 21:54 Third-party testing 2,764 +38 ArchiveBot (talk | contribs) bot: add maintenance category [rollback]
  2. (diff | hist) 21:47 SELECT trial 1,788 +599 TriumphThad (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  3. (diff | hist) 17:54 Reference standard 2,461 +464 LotTraceLuka (talk | contribs) add the note on co-elution and what it hides [rollback]
  4. (diff | hist) 05:58 Sterile water for injection 1,225 ±0 Chromatokid (talk | contribs) the example withdrew more than the syringe holds; corrected [rollback]
  5. (diff | hist) 05:17 Karl Fischer titration 2,813 +314 SigFigSindri (talk | contribs) expand §Interpretation on a certificate of analysis [rollback]
  6. (diff | hist) N 04:33 PeptideMeter 1,176 +1,176 EndotoxinEd (talk | contribs) start article on the testing subject

19 August 2024

  1. (diff | hist) N 22:36 Certificate of analysis 1,858 +1,858 COA_Colwyn (talk | contribs) create article — testing stub
  2. (diff | hist) 18:08 Retatrutide 3,206 +484 GMP_Gita (talk | contribs) add CAS number, sourced [rollback]
  3. (diff | hist) 15:40 Analytical method validation 2,439 +341 KarlFischerKit (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  4. (diff | hist) m 06:51 Haemoglobin A1c 1,822 ±0 SerialCommaSeb (talk | contribs) add the interference the assay is known to be subject to [rollback]

18 August 2024

  1. (diff | hist) 23:39 GL Biochem (Shanghai) 5,325 +1,045 UnitsUrsula (talk | contribs) expand §Regulatory position and legal status [rollback]
  2. (diff | hist) 22:22 Proglucagon 2,661 +423 GMP_Gita (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]
  3. (diff | hist) 22:03 Satiety signalling 1,326 ±0 AmylinAmos (talk | contribs) add category for receptor pharmacology [rollback]
  4. (diff | hist) m 14:43 Lot traceability 2,004 ±0 EndotoxinEd (talk | contribs) split overlong sentence [rollback]
  5. (diff | hist) 10:32 Insulin syringe 2,083 ±0 CarryOverCai (talk | contribs) rm the individualised advice — the article describes, it does not instruct [rollback]
  6. (diff | hist) N 09:11 Loss on drying 1,231 +1,231 KarlFischerKit (talk | contribs) start article on the analytical method

17 August 2024

  1. (diff | hist) 23:09 Cold chain 7,610 +778 PancreasPru (talk | contribs) de-duplicate a repeated sentence [rollback]
  2. (diff | hist) m 21:16 Cagrilintide 1,293 ±0 COA_Colwyn (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  3. (diff | hist) 13:04 Batch number 1,993 ±0 Chromatokid (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  4. (diff | hist) 06:20 Hypoglycaemia 1,779 ±0 BiliaryBea (talk | contribs) expand §Why glucose dependence matters [rollback]
  5. (diff | hist) 03:22 SURMOUNT trial programme 2,057 ±0 Chromatokid (talk | contribs) space between number and unit per PP:MOS [rollback]

16 August 2024

  1. (diff | hist) m 20:59 Limit of detection 1,742 +759 IsocraticIla (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  2. (diff | hist) 12:48 Dipeptidyl peptidase-4 3,295 +240 ArcuateArt (talk | contribs) expand §Analytical relevance [rollback]
  3. (diff | hist) 12:43 Nantong Guangyuan Chemical 2,793 +38 BlankVialBo (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  4. (diff | hist) 12:12 Peptide 2,681 ±0 CDMO_Caradoc (talk | contribs) expand §Peptides in research supply [rollback]
  5. (diff | hist) 11:48 Chinese Peptide Company 2,675 +457 ForestPlotFinn (talk | contribs) typo [rollback]
  6. (diff | hist) 09:24 List of GLP-1 receptor agonists 1,884 ±0 SortKeySascha (talk | contribs) add the criterion for inclusion to the lead [rollback]
  7. (diff | hist) 08:52 Talk:WuXi TIDES 1,244 +96 Chromatokid (talk | contribs) /* Notability, and the name problem */ reply
  8. (diff | hist) m 01:24 High-performance liquid chromatography 3,179 +270 ForestPlotFinn (talk | contribs) expand §What the chromatogram reports [rollback]
  9. (diff | hist) 01:12 Liraglutide 2,493 +1,051 SemaglutideSasha (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]

15 August 2024

  1. (diff | hist) 22:34 Preparative HPLC purification 1,366 ±0 CrudePeptidePearl (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  2. (diff | hist) m 20:08 Glucagon-like peptide-1 5,430 +569 ProglucagonPia (talk | contribs) add the reference range with the assay it was established on [rollback]
  3. (diff | hist) 17:16 GLP-1 receptor 3,714 +239 CustomsClarke (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]
  4. (diff | hist) 11:31 Talk:WuXi TIDES 1,033 +215 ScopeSeverin (talk | contribs) /* Notability, and the name problem */ reply
  5. (diff | hist) m b 11:30 Reconstitution of lyophilised peptides 2,854 +38 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  6. (diff | hist) N 09:00 Retention time 986 +986 TrialsTabitha (talk | contribs) new article: analytical method, expansion welcome

14 August 2024

  1. (diff | hist) 21:05 Semaglutide 4,803 +891 BatchNumberBede (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  2. (diff | hist) 20:33 SUSTAIN trial programme 2,571 +625 EndpointEnid (talk | contribs) add the missing-data handling method [rollback]